SHIFT Newsroom · GLOBAL
Oral VK2735: sponsor update and trial records still differ
Viking says SUNRISE tablet trials are underway. Records checked on 29 October still list estimated November starts and no posted results.
Viking’s 28 October 2026 business update says the SUNRISE Phase 3 trials of oral VK2735 are underway. Initiation had originally been announced on 14 October, so this is a follow-up to that announcement, not a newly announced trial programme. [1]
What the records currently say
The SUNRISE-1 and SUNRISE-2 records were checked again on 29 October. Both still list “not yet recruiting”, an estimated November 2026 start and 560 planned participants. Their latest posted updates are dated 16 October. Neither contains posted results. [2,3]
The sponsor’s wording and the public registry status therefore remain different. These sources do not establish the actual first-participant dosing date.
What is being tested
Viking describes two 68-week studies of a daily tablet, including a study in adults with type 2 diabetes. The planned study sizes and schedules describe research design; they are not Phase 3 evidence that the tablet works. [1]
The oral maintenance schedule described in the programme is daily, not weekly.
What it means for UK readers
The development adds to the emerging pill category. These announcements and records do not establish UK authorisation, NHS access or pharmacy supply. Trial dosing descriptions are not instructions to change treatment.
Follow further evidence through the SHIFT Newsroom.
Sources and evidence
1. Viking Therapeutics — Third-quarter results and corporate update, published 28 October 2026.
2. ClinicalTrials.gov — SUNRISE-1, NCT07868835, last update posted 16 October 2026; structured record checked 29 October.
3. ClinicalTrials.gov — SUNRISE-2, NCT07868939, last update posted 16 October 2026; structured record checked 29 October.
SHIFT’s take
This is emerging oral-treatment research. The registry and sponsor wording do not establish UK authorisation, NHS access or pharmacy supply.
Known facts
- Neither contains posted results.
- The oral maintenance schedule described in the programme is daily, not weekly.